A polynucleotide is a long chain of nucleotides linked end to end, forming the molecular backbone of DNA and RNA. Each nucleotide in the chain consists of three parts: a sugar, a phosphate group, and a nitrogen-containing base. When hundreds or thousands of these units snap together through chemical bonds, the resulting strand is what biologists call a polynucleotide. These molecules carry genetic information, regulate how cells behave, and increasingly serve as the basis for modern medicines, but the way they do all of that depends on structural details worth understanding.
How Nucleotides Link Into a Chain
A single nucleotide on its own is just a small molecule. It becomes part of a polynucleotide when its phosphate group bonds to the sugar of the neighboring nucleotide, forming what chemists call a phosphodiester bond. Specifically, the phosphate at the 5ʹ carbon of one sugar connects to the 3ʹ carbon of the next sugar, creating a continuous sugar-phosphate backbone that runs along the length of the strand.1Biology Online. What Is a Polynucleotide? Definition, Structure, and Types This directionality matters: every polynucleotide strand has a 5ʹ end and a 3ʹ end, and biological machinery always reads and builds them in a specific direction. The bases, meanwhile, stick out sideways from the backbone like teeth on a comb, ready to pair with complementary bases on an opposing strand or fold into complex shapes on their own.
The four bases in DNA are adenine, guanine, cytosine, and thymine. RNA uses the same first three but swaps thymine for uracil. These bases pair in predictable ways: adenine with thymine (or uracil in RNA), and guanine with cytosine. That pairing is what allows DNA to form its famous double helix and what lets RNA fold into functional three-dimensional structures. The sequence of bases along a polynucleotide is the information itself, encoding everything from the color of your eyes to the enzymes that digest your lunch.
DNA and RNA Are Both Polynucleotides, but They Differ in Key Ways
DNA and RNA are often discussed as though they belong to entirely different categories, but structurally they are both polynucleotides. The differences between them are small in chemical terms yet enormous in biological consequence. DNA’s sugar is deoxyribose, which is missing one oxygen atom that ribose (RNA’s sugar) has. That missing oxygen makes DNA more chemically stable, which is why cells use it for long-term information storage. RNA, with its extra oxygen on the 2ʹ position of the sugar ring, is more reactive and breaks down faster, but that very instability makes it useful for temporary tasks.
The presence or absence of that 2ʹ hydroxyl group also changes the physical shape a polynucleotide prefers. DNA most commonly adopts the B-form helix, the wide, gently twisted structure you see in textbook illustrations. RNA helices tend to take the A-form, which is shorter and wider with bases tilted relative to the helix axis. Research on how these structural differences affect stability has shown that both the 2ʹ hydroxyl group and the methyl group unique to thymine independently influence how tightly a helix holds together, and their effects can reinforce or oppose each other depending on the type of structure involved.2PubMed Central. Origins of the large differences in stability of DNA and RNA helices: C-5 methyl and 2′-hydroxyl effects In practical terms, this means RNA and DNA do not just carry different information but physically behave differently, folding and interacting with proteins in distinct ways.
Types of RNA Polynucleotides
While DNA essentially has one job (storing the genome), RNA polynucleotides come in a remarkable variety of forms, each with a specialized function. The three classical types are messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). mRNA carries the instructions copied from DNA to the cell’s protein-building machinery. tRNA acts as a molecular adapter, fetching individual amino acids and delivering them to the growing protein chain. rRNA forms the structural and catalytic core of the ribosome itself.
Beyond these three, cells produce a sprawling cast of non-coding RNA polynucleotides that never get translated into protein but still play critical roles. MicroRNAs, for instance, are tiny polynucleotides roughly 20 to 25 nucleotides long that regulate gene expression by latching onto messenger RNAs and either blocking their translation or promoting their destruction.3PubMed Central. Mechanistic Insights into MicroRNA-Mediated Gene Silencing Small interfering RNAs work through a related mechanism and have become a standard research tool for selectively silencing genes in the lab.4PubMed Central. Molecular mechanisms of RNA-triggered gene silencing machineries Long non-coding RNAs, some stretching thousands of nucleotides, are still being catalogued, and scientists continue to discover new functions for them in development and disease.
When RNA Acts Like an Enzyme
One of the more surprising discoveries about polynucleotides is that RNA can act as a catalyst, speeding up chemical reactions the way protein enzymes do. These catalytic RNA molecules are called ribozymes. The ribosome, which builds every protein in your body, is fundamentally an RNA machine: the critical step of joining amino acids together is catalyzed by an RNA component, not a protein one.5PubMed Central. Mechanisms of catalytic RNA molecules Other ribozymes handle tasks like splicing RNA transcripts and processing other RNA molecules. Some work alone; others, like the ribosome and the spliceosome, require protein partners to function properly in the cell.
The catalytic ability of RNA polynucleotides has profound implications for understanding how life began. If RNA can both store information (like DNA) and catalyze reactions (like proteins), then early life forms might not have needed both DNA and proteins at the start. This reasoning underpins the RNA World hypothesis, which proposes that self-replicating RNA polynucleotides preceded the DNA-and-protein world we know today.6PubMed. The RNA World as a Model System to Study the Origin of Life Researchers have made progress showing that RNA can, in principle, copy itself, though getting that to work efficiently under conditions resembling early Earth remains one of the great open challenges in origin-of-life research.7PubMed Central. The origins of the RNA world
Non-Canonical Structures
When people picture a polynucleotide, they usually think of the classic B-form double helix. But DNA can fold into a surprising range of alternative shapes depending on its sequence and local environment. These non-canonical structures include hairpins (where a single strand folds back on itself), cruciforms (cross-shaped structures formed by sequences that are palindromic), Z-DNA (a left-handed helix rather than the usual right-handed one), G-quadruplexes (formed in guanine-rich regions where four strands interweave), and i-motif structures (formed by cytosine-rich sequences at low pH).8PubMed Central. Non-canonical DNA structures: Diversity and disease association
These shapes are not just curiosities. G-quadruplexes, for example, tend to form at the ends of chromosomes and in the regulatory regions of certain genes, and their presence can influence whether a gene gets turned on or off. When non-canonical structures form in the wrong place or at the wrong time, they can interfere with DNA replication or repair, and accumulating evidence links them to genetic instability and disease. The idea that DNA is a static, uniform helix dramatically undersells its structural versatility.
Building Polynucleotides in the Lab
Cells build polynucleotides using enzymes like DNA polymerase and RNA polymerase, copying existing templates one nucleotide at a time. In the laboratory, chemists synthesize custom polynucleotides using a different approach. The dominant method, developed in the early 1980s, relies on a technique called solid-phase synthesis using phosphoramidite chemistry.9PubMed. Chemical Synthesis of Oligonucelotide Sequences: Phosphoramidite Chemistry The process anchors the first nucleotide to a solid bead, then adds nucleotides one at a time in a carefully controlled cycle of chemical reactions, building the chain from the 3ʹ end toward the 5ʹ end.
Each cycle involves removing a protective chemical cap from the growing chain, coupling the next nucleotide, capping any chains that failed to react, and then oxidizing the new bond to stabilize it. Modern automated synthesizers can repeat this cycle dozens of times, producing short polynucleotides (called oligonucleotides) on the order of 20 to 200 nucleotides long with high precision. Recent advances have pushed the technology further: flow-chemistry methods can now produce the phosphoramidite building blocks themselves in under six minutes with near-complete conversion, streamlining the supply chain for custom polynucleotide production.10Nature Communications. On-demand synthesis of phosphoramidites
The ability to synthesize polynucleotides to order has transformed biology. Researchers routinely order custom DNA sequences online and receive them by mail within days. These synthetic polynucleotides serve as primers for DNA amplification, probes for detecting specific genes, guides for gene-editing tools, and building blocks for entirely artificial gene circuits.
Reading Polynucleotide Sequences
Knowing the exact sequence of bases in a polynucleotide is essential for everything from diagnosing genetic diseases to tracking how viruses evolve. Over the past fifty years, sequencing technologies have gone from painstaking manual chemistry to automated platforms capable of reading billions of bases in a single run.11PubMed Central. The sequence of sequencers: The history of sequencing DNA Early methods worked by making copies of a DNA strand that terminated at random positions, then sorting the fragments by size to deduce the sequence one letter at a time.
A newer approach involves threading single polynucleotide molecules through a tiny protein pore (a nanopore) embedded in a membrane. As the strand passes through, each base causes a characteristic disruption in the electrical current flowing through the pore, allowing the sequence to be read in real time. Research demonstrated that nanopores can distinguish between polynucleotides of similar length and composition that differ only in their base sequence, opening the door to fast, label-free sequencing at extremely low copy numbers.12PubMed. Rapid nanopore discrimination between single polynucleotide molecules Nanopore sequencers are now compact enough to fit in a pocket and have been used in settings ranging from remote field stations to the International Space Station.
Polynucleotides in Modern Medicine
The COVID-19 vaccines from Pfizer-BioNTech and Moderna brought mRNA polynucleotides into the public spotlight, but therapeutic use of nucleic acids has been developing for decades. The basic idea is straightforward: deliver a synthetic polynucleotide into cells so that it either provides instructions for making a useful protein (as with mRNA vaccines) or silences a harmful gene (as with antisense and siRNA drugs).
A major challenge with using polynucleotides as drugs is that the body is full of enzymes designed to chew them up. Nucleases, which are enzymes that cut phosphodiester bonds, are everywhere in the blood and inside cells.13PubMed Central. Nucleases: diversity of structure, function and mechanism To get around this, scientists modify the polynucleotide’s chemistry. Replacing certain nucleotides with modified versions, such as pseudouridine or N1-methylpseudouridine, makes the strand more resistant to enzymatic breakdown and also reduces the inflammatory response the body would normally mount against foreign RNA.14PubMed Central. Pseudouridine and N1-methylpseudouridine as potent nucleotide analogues for RNA therapy and vaccine development These modifications were essential to making mRNA vaccines practical.
Delivery is the other half of the problem. Naked polynucleotides cannot cross cell membranes easily, so most RNA therapeutics are packaged inside lipid nanoparticles. These tiny fat bubbles protect the RNA in the bloodstream and help it enter cells. The lipids used are specially designed to carry a positive charge at low pH, which allows them to bind the negatively charged RNA during manufacturing, but become neutral at the body’s normal pH to reduce toxicity.15PubMed Central. Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery Once inside a cell, the nanoparticle needs to release its cargo from the compartment it gets trapped in (a process called endosomal escape), and the shape and packing of the lipids play a key role in how efficiently that happens.16PubMed Central. Lipid shape and packing are key for optimal design of pH-sensitive mRNA lipid nanoparticles
Polynucleotides in Skin and Wound Healing
Outside of vaccines and gene therapies, polynucleotides have found a growing niche in aesthetic and regenerative medicine. Products based on polydeoxyribonucleotide (PDRN), which consists of short DNA fragments typically extracted from salmon sperm cells, are used in clinics for skin rejuvenation, wound healing, and tissue repair. PDRN fragments have molecular weights ranging from 50 to 1,500 kilodaltons and work by activating a specific cell-surface receptor (the adenosine A2A receptor) along with salvage pathways that recycle nucleotide components.17Chinese Journal of Plastic and Reconstructive Surgery. Polydeoxyribonucleotide: A promising skin anti-aging agent
Studies have reported that PDRN promotes blood vessel growth, stimulates collagen production, reduces inflammation, and accelerates healing in chronic wounds and ulcers. In aesthetic clinics, it is injected or applied topically to improve skin texture, elasticity, and hydration. The appeal is that these are not foreign drugs in the traditional sense but fragments of a molecule found in every living cell, which may partly explain their generally favorable safety profile. The field is still relatively young, and much of the evidence comes from preclinical work and small clinical trials, so the strength of the claims varies depending on the specific application.
Artificial and Modified Polynucleotides
Researchers are no longer limited to the two natural polynucleotide backbones. Xeno nucleic acids (XNAs) are synthetic polynucleotides in which the sugar, the phosphate linkage, or both have been replaced with alternative chemistry. Some use threose instead of ribose; others substitute the entire sugar-phosphate backbone with a peptide chain or a morpholine ring. These modifications can make the polynucleotide invisible to nucleases, dramatically increasing its stability in biological fluids. XNAs are increasingly being subjected to directed evolution in the lab, allowing scientists to select artificial polynucleotides that bind specific targets or catalyze reactions, expanding the functional repertoire beyond what natural DNA and RNA can do.18PubMed Central. Modified nucleic acids: replication, evolution, and next-generation therapeutics
The therapeutic potential is considerable. First-generation nucleic acid drugs often struggled with rapid degradation and poor cell uptake, and while lipid nanoparticles and chemical modifications have improved things enormously, XNA-based approaches could push the boundaries further. An aptamer made from a nuclease-resistant XNA backbone, for instance, could circulate in the blood far longer than a natural RNA aptamer, reducing how often a patient needs dosing. The technology is still mostly in the research phase, but it illustrates how flexible the polynucleotide concept really is: change the chemistry, and the same information-carrying architecture can be tuned for entirely new purposes.
How Polynucleotides Break Down
Understanding how polynucleotides are degraded is just as important as understanding how they are built. Cells maintain a large toolkit of nucleases, enzymes that cleave the phosphodiester bonds holding the chain together.13PubMed Central. Nucleases: diversity of structure, function and mechanism Some nucleases chew from the ends (exonucleases), while others cut in the middle of the strand (endonucleases). Some are specific to DNA, others to RNA, and some are not picky at all.
This degradation is not a flaw; it is essential housekeeping. Cells need to destroy messenger RNA after it has been read enough times, dismantle damaged DNA during repair, and clear out foreign nucleic acids from invading viruses. The mRNA in your cells typically lasts only minutes to hours before nucleases recycle it. DNA, protected inside the nucleus and wrapped around proteins, survives much longer but is still subject to constant repair and occasional dismantling. The interplay between polynucleotide synthesis and degradation is what keeps the whole system dynamic, allowing cells to respond to changing conditions by ramping specific RNA polynucleotides up or down as needed.
For mRNA vaccines and other nucleic acid therapeutics, nuclease activity is the main adversary. Every design choice, from the modified nucleotides to the lipid shell to the addition of a protective cap at the 5ʹ end and a poly(A) tail at the 3ʹ end, is in part a strategy to buy more time before nucleases destroy the molecule. Research has shown that the cap and the poly(A) tail work together to boost translation efficiency, with the tail’s benefit being entirely dependent on the presence of the cap.19PubMed. The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency Designing effective mRNA therapeutics means understanding not just what you want the polynucleotide to say but how long it needs to survive to say it.